Sarissa Capital Management as of Sept. 30, 2015
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 18 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbvie (ABBV) | 21.2 | $86M | 1.6M | 54.41 | |
| Ariad Pharmaceuticals | 18.5 | $75M | 13M | 5.84 | |
| Medicines Company | 14.7 | $60M | 1.6M | 37.96 | |
| Quest Diagnostics Incorporated (DGX) | 8.7 | $35M | 575k | 61.47 | |
| Aegerion Pharmaceuticals | 8.6 | $35M | 2.6M | 13.60 | |
| Intra Cellular Therapies (ITCI) | 6.3 | $26M | 640k | 40.04 | |
| Merck & Co (MRK) | 4.9 | $20M | 400k | 49.39 | |
| Pacira Pharmaceuticals (PCRX) | 3.9 | $16M | 380k | 41.10 | |
| Amgen (AMGN) | 3.1 | $12M | 90k | 138.32 | |
| Esperion Therapeutics (ESPR) | 2.6 | $11M | 448k | 23.59 | |
| Apricus Bioscience | 2.4 | $9.5M | 6.5M | 1.46 | |
| Repros Therapeutics | 2.1 | $8.4M | 1.1M | 7.43 | |
| Vivus | 1.0 | $4.2M | 2.6M | 1.64 | |
| Kindred Biosciences | 0.9 | $3.6M | 689k | 5.20 | |
| AVEO Pharmaceuticals | 0.7 | $2.8M | 2.3M | 1.21 | |
| Biosante Pharmaceuticals (ANIP) | 0.3 | $1.2M | 31k | 39.52 | |
| Catalyst Biosciences | 0.1 | $419k | 90k | 4.66 | |
| Eleven Biotherapeutics | 0.0 | $99k | 41k | 2.40 |
